AXA Framlington Biotech R Class Acc

Register to Unlock Ratings
Performance History30/09/2021
Growth of 1,000 (GBP) Advanced Graph
AXA Framlington Biotech R Class Acc
Fund8.5-7.318.131.45.9
+/-Cat-1.70.6-2.15.56.4
+/-B’mrk-2.6-4.1-2.18.9-2.9
 
Key Stats
NAV
21/10/2021
 GBX 246.40
Day Change -0.12%
Morningstar Category™ Sector Equity Biotechnology
IA (formerly IMA) Sector Specialist
ISIN GB0031007254
Fund Size (Mil)
30/09/2021
 GBP 473.29
Share Class Size (Mil)
21/10/2021
 GBP 68.95
Max Initial Charge 5.50%
Ongoing Charge
24/09/2021
  1.82%
Investment Objective: AXA Framlington Biotech R Class Acc
The aim of this Fund is to provide long-term capital growth. The Fund invests in shares of listed companies, principally in the biotechnology, genomic and medical research industry, which the Manager believes will provide above-average returns. The Fund invests in companies of any size which can be based anywhere in the world, albeit the Fund tends to be biased towards the US as this is where the majority of biotechnology companies are based. The Manager selects shares based upon analysis of a company’s financial status, quality of its management, expected profitability and prospects for growth.
Returns
Trailing Returns (GBP)21/10/2021
YTD1.40
3 Years Annualised9.75
5 Years Annualised9.41
10 Years Annualised18.39
12 Month Yield 0.00
Management
Manager Name
Start Date
Linden Thomson
05/07/2012
Peter Hughes
01/04/2018
Inception Date
26/11/2001
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology TR USDNASDAQ Biotechnology TR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNo
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  AXA Framlington Biotech R Class Acc31/08/2021
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock97.100.0097.10
Bond0.000.000.00
Property0.000.000.00
Cash3.480.582.90
Other0.000.000.00
Top 5 Regions%
United States88.64
Asia - Emerging3.48
Europe - ex Euro3.48
Eurozone2.93
United Kingdom1.47
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Regeneron Pharmaceuticals IncHealthcareHealthcare7.86
Moderna IncHealthcareHealthcare7.38
Gilead Sciences IncHealthcareHealthcare6.18
Biogen IncHealthcareHealthcare5.35
Amgen IncHealthcareHealthcare4.51
AXA Framlington Biotech R Class Acc

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)